Skip to main content

Plott Ronald Todd's Form 4 filing

Phio Pharmaceuticals Corp.PHIO · filed Aug 20, 2026

Accession no.
0001683168-26-006620
Filed
Aug 20, 2026, 8:30 AM ET
Trade date
Aug 19, 2026
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market purchases total $17.1K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Plott Ronald ToddCIK 0001768337Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 19, 2026Common Stock, $.0001 par valuePPurchaseAcquired+15,000$1.14+$17,10015,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)